IRIS
PISANI, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.601
NA - Nord America 6.052
AS - Asia 3.816
SA - Sud America 1.782
AF - Africa 104
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.369
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.942
RU - Federazione Russa 3.714
SG - Singapore 1.699
BR - Brasile 1.565
CN - Cina 1.036
IE - Irlanda 961
SE - Svezia 760
IT - Italia 501
HK - Hong Kong 441
UA - Ucraina 409
DE - Germania 396
FR - Francia 271
VN - Vietnam 200
FI - Finlandia 197
GB - Regno Unito 161
IN - India 101
AR - Argentina 78
PL - Polonia 63
IQ - Iraq 50
TR - Turchia 50
MX - Messico 42
CA - Canada 40
BD - Bangladesh 36
AT - Austria 35
EC - Ecuador 35
NL - Olanda 35
ZA - Sudafrica 29
BE - Belgio 28
UZ - Uzbekistan 26
MA - Marocco 24
JP - Giappone 23
PK - Pakistan 23
CO - Colombia 20
VE - Venezuela 20
CL - Cile 17
ID - Indonesia 16
PY - Paraguay 16
PE - Perù 13
SA - Arabia Saudita 13
ES - Italia 10
LT - Lituania 10
OM - Oman 10
TN - Tunisia 10
IR - Iran 9
JO - Giordania 9
PH - Filippine 9
UY - Uruguay 9
BO - Bolivia 8
CZ - Repubblica Ceca 8
JM - Giamaica 8
KE - Kenya 8
KZ - Kazakistan 8
PA - Panama 8
AE - Emirati Arabi Uniti 7
IL - Israele 7
AU - Australia 6
EG - Egitto 6
AZ - Azerbaigian 5
CH - Svizzera 5
KR - Corea 5
RS - Serbia 5
DZ - Algeria 4
ET - Etiopia 4
HN - Honduras 4
KG - Kirghizistan 4
LB - Libano 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
EU - Europa 3
GR - Grecia 3
PS - Palestinian Territory 3
RO - Romania 3
SN - Senegal 3
AM - Armenia 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CR - Costa Rica 2
CY - Cipro 2
GA - Gabon 2
GE - Georgia 2
HR - Croazia 2
KW - Kuwait 2
MK - Macedonia 2
MY - Malesia 2
NG - Nigeria 2
NI - Nicaragua 2
NP - Nepal 2
SI - Slovenia 2
TG - Togo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BJ - Benin 1
DK - Danimarca 1
EE - Estonia 1
GY - Guiana 1
Totale 19.353
Salva come PNG Salva come JPEG
Città #
Moscow 1.240
Dublin 958
Jacksonville 828
Singapore 803
Chandler 699
Ashburn 588
Dallas 495
Hong Kong 441
Beijing 384
Nyköping 321
The Dalles 235
Dearborn 193
Princeton 189
Cambridge 179
Lauterbourg 167
Los Angeles 162
Des Moines 148
San Jose 138
Medford 125
São Paulo 117
Ann Arbor 116
Boardman 98
Buffalo 89
Ho Chi Minh City 84
New York 80
Warsaw 59
Rio de Janeiro 57
Tianjin 54
Messina 49
Wilmington 47
Woodbridge 47
Munich 44
Hanoi 40
San Mateo 40
Shenyang 40
Belo Horizonte 38
Guangzhou 36
Jinan 35
Milan 35
Houston 34
Rome 32
Orem 31
Redondo Beach 30
Nanjing 29
Brussels 27
Curitiba 27
Frankfurt am Main 25
Vienna 24
Santa Clara 23
Seattle 23
Tashkent 23
Bremen 22
Pune 22
Salvador 22
Hebei 20
Porto Alegre 20
Brasília 19
Campinas 19
Amsterdam 18
Stockholm 18
Tokyo 18
Brooklyn 17
Chennai 17
Chicago 17
Manchester 17
Mumbai 17
Montreal 16
Norwalk 16
Zhengzhou 16
Atlanta 15
Denver 15
Guayaquil 15
Jiaxing 15
Ningbo 15
Shenzhen 15
Fortaleza 14
Guarulhos 14
Hangzhou 14
Lancaster 14
Ribeirão Preto 14
Shanghai 14
Helsinki 13
Istanbul 13
Johannesburg 13
Poplar 13
Fuzhou 12
Haikou 12
London 12
Mexico City 12
Naples 12
Recife 12
Baghdad 11
Caruaru 11
Council Bluffs 11
Goiânia 11
Nuremberg 11
Phoenix 11
Sorocaba 11
Muscat 10
Santo André 10
Totale 10.552
Salva come PNG Salva come JPEG
Nome #
" Stato confusionale di probabile natura iatrogena"; " Verosimile screzio psicotico"; " Sindrome Cefalalgica"; " Disturbo d'Ansia". Varie ipotesi ed una sola diagnosi: SENC 435
Antiepileptic drugs and MTHFR Polymorphisms influence hyper-homocysteinemia recurrence in epileptic patients 207
"Valproic acid-amitriptyline interaction in man 197
ALLOPURINOL AS ADD-ON THERAPY IN REFRACTORY EPILEPSY - A DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY 193
Distribuzione di due polimorfismi genici della MTHFR in pazienti con Epilessia e correlazione con i livelli serici di omocisteina 179
ATTENTION CHARACTERIZATION IN PATIENTS WITH FRONTAL AND TEMPORAL LOBE EPILEPSY 179
beneficial effect of donezepil in a malnourished surgical patient with severe nonalcoholic wernicke's encephalopathy 178
Controllo totale di crisi con l’associazione lamotrigina-gabapentin in un caso di epilessia sintomatica. 173
Rischio di iperomocisteinemia in pazienti con Epilessia, portatori del diplotipo C677T/A1298C della MTHFR 172
Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review 172
Differential distribution of epilepsy in patients with different types of dementia: a single-centre, retrospective study 171
Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study 169
Aspetti neuropsichiatrici dell'epilessia 166
An epidemiological study of the clinical impact of pharmacokinetic anticonvulsant drug interactions based on serum drug level analysis 166
FORCED NORMALISATION: OBSERVATION WITH NEW ANTIEPILEPTIC DRUGS 165
Non-convulsive status epilepticus after ischemic stroke: a hospital-based stroke cohort study 165
FORCED NORMALISATION: A RETROSPECTIVE ANALYSIS OF RISK FACTORS 164
A sensitive gas chromatograpic assay for the determination of serum viloxazine concetration using a nitrogen-phosphorus selective detector". Ther. Drug Monit., 6:484-488, 1984. 164
Hyperhomocysteinemia and retinal vascular changes in patients with epilepsy. 160
Antidepressant drugs and seizure susceptibility: From in vitro data to clinical practice 158
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD 156
A study on the metabolism of dipropylacetamide to dipropylacetic acid in rats 156
Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia 154
Repetitive transcranial magnetic stimulation induced slow wave activity modification: A possible role in disorder of consciousness differential diagnosis? 153
Effect of viloxazine on serum carbamazepine levels in epileptic patients 151
Is retinal assessment useful in epileptic patients with hyperhomocysteinemia? 150
Hyperhomocysteinemia in patients with epilepsy: does it play a role in the pathogenesis of brain atrophy? A preliminary report. 149
A critical role of NO/cGMP/PKG dependent pathway in hippocampal post-ischemic LTP: modulation by zonisamide 144
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) 143
CARBAMAZEPINE VALNOCTAMIDE INTERACTION IN EPILEPTIC PATIENTS - IN-VITRO IN-VIVO CORRELATION 143
Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs 142
Effects of psychotropic drugs on seizure threshold 141
Carbamazepine-viloxazine interaction in patients with epilepsy 141
Diurnal fluctuations in plasma drug levels:studies with valproic acid and carbamazepine 140
Dipropylacetic acid plasma levels; diurnal fluctuations during chronic treatment with dipropylacetamide 139
Effect of valpromide on the pharmacokinetics of Carbamazepine-10,11-epoxide 139
Accidents in patients with epilepsy: types, circumstances, and complications: a European cohort study 136
Antiepileptic drug comedications in clinical practice 136
The contribution of inter-ictal SPECT in the evaluation of patients with epilepsy: Possible additional uses on the basis of selected cases [Il contributo della SPECT inter-critica nella valutazione del paziente con epilessia: Possibili ulteriori indicazioni sulla base di alcuni casi selezionati] 134
Identification of amoebae in the CSF in a patient with meningoencephalitis. 133
THE EFFECT OF COMBINING VIGABATRIN AND TIAGABINE, TWO DRUGS WITH COMPLEMENTARY GABAERGIC MECHANISMS, AGAINST NMDA-INDUCED EXCITOTOXICITY 132
Attivita' parossistica ed agenti farmacologici: attivazione ed inibizione 132
Prevenzione dell’epilettogenesi: revisione della letteratura, raccomandazioni terapeutiche, proposte di ricerca 128
Neuroprotective effects of levetiracetam against kainic acid toxicity are mediated by inhibition of lipid peroxidation 127
Normalizzazione forzata e fattori di rischio: un'analisi retrospettiva 127
Crisi epilettiche indotte dall’assunzione di leflunamide in pazienti in terapia con carbamazepina 127
Differential interactions of valproic acid and valpromide with Carbamazepine in man 127
Disturbi del linguaggio e farmaci antiepilettici: analisi prospettica dei possibili fattori di rischio 126
Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics. 125
Prime esperienze su efficacia e tollerabilità della tiagabina in pazienti con epilessia farmacoresistente 124
The effect of lamotrigine on peripheral nerves. 122
COULD LAMOTRIGINE BE USEFUL IN STATUS EPILEPTICUS - A CASE- REPORT 121
Meccanismi eccitotossici in un modello sperimentale in vitro: effetti della lamotrigina sul rilascio di amminoacidi eccitatori 120
CONTRIBUTION OF INTERICTAL BRAIN PERFUSION SPECT IN ASSESSING PATIENTS WITH EPILEPSY 116
Lamotrigina ed effetti elettrofisiologici sul sistema nervoso periferico. 115
Effetto della viloxazina sui livelli ematici di oxcarbazepina e dei relativi metaboliti 115
Lamotrigina ed effetti elettrofisiologici sul sistema nervoso periferico 114
Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs. 113
INFLUENCE OF COMEDICATION ON THE METABOLISM OF VALPROATE 109
Ruolo dei farmaci antiepilettici nella neuroprotezione da ischemia cerebrale 109
Neuroprotective effect of remacemide hydrochloride against NMDA-induced excitotoxicity in isolated chick embryo retina 107
Evaluation of Tricyclic Antidepressant Plasma Levels by an Automated Enzyme Immunoassay (EMIT) in Comparison to a High-Performance Liquid Chromatographic Method 105
Epilepsy Study Group of the Italian Neurological Society. Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis. 105
ELEVATION OF PLASMA PHENYTOIN BY VILOXAZINE IN EPILEPTIC PATIENTS - A CLINICALLY SIGNIFICANT DRUG-INTERACTION 104
Effects of remacemide and lamotrigine on MNDA-induced excitotoxicity in isolated chick embryo retina 104
Pharmacokinetics of the antidepressant drug viloxazine in normal subjects and in epileptic patients receiving chronic anticonvulsant treatment 104
The 894G > T (Glu298Asp) variant in the endothelial NOSgene and MTHFR polymorphisms influence homocysteine levels in patients withcognitive decline. 104
Specific Patient Features Affect Antiepileptic Drug Therapy Decisions: Focus on Gender, Age, and Psychiatric Comorbidities 104
Effect of enzyme inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients 103
Il concetto di normalizzazione forzata in epilettologia 103
Single-dose kinetics of primidone in acute viral hepatitis 103
Efficacia della lamotrigina nelle crisi con caduta 102
Pharmacokinetics and therapeutic plasma monitoring of antiepileptic drugs 101
Coenzyme Q10, Hyperhomocysteinemia and MTHFR C677T polymorphism in Levodopa-treated Parkinson’s disease patients 101
Risk factors for unprovoked epileptic seizures in multiple sclerosis: a systematic review and meta-analysis 101
EFFECTS OF THE ANTIDEPRESSANT DRUG VILOXAZINE ON OXCARBAZEPINE AND ITS HYDROXYLATED METABOLITES IN PATIENTS WITH EPILEPSY 99
INTERACTION OF LAMOTRIGINE WITH SODIUM VALPROATE 99
Increased dipropylacetic acid bioavailability from dipropylacetamide by food 98
Objective cognitive dysfunction assessment in patients with subjective cognitive complaints: does it allow an early differentiation between demnetia and pseudo-dementia? 98
Marcato effetto sinergico terapeutico dell'associazione lamotrigina-valproato in pazienti con epilessia farmaco-resistente 98
Liquid chromatographic assay of lamotrigine,a new antiepileptic drug, by a hig-speed column 96
The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: Evidence for a pharmacodynamic interaction 96
Morbidity in patients with epilepsy: type and complications: a European cohort study 96
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study 96
Pharmacokinetics of phenylethylmalonamide (PEMA) after oral and intravenous administration 96
Sodium valproate and valpromide:Differential interactions with carbamazepine in epileptic patients 96
The importance of drug interactions in epilepsy therapy 95
Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy 95
VIGABATRIN-INDUCED DECREASE IN SERUM PHENYTOIN CONCENTRATION DOES NOT INVOLVE A CHANGE IN PHENYTOIN BIOAVAILABILITY 94
Screening for C677T and A1298C MTHFR polymorphisms in patients with epilepsy and risk of hyperhomocysteinemia 94
Phenylethylmalonamide in essential tremor.A double-blind controlled study 94
Interazione della carbamazepina con la valnoctamide: dati "in vitro" ed in pazienti con epilessia 94
CLINICALLY RELEVANT ANTI-EPILEPTIC DRUG-INTERACTIONS 93
Valproic acid-ethosuximide interaction: A pharmacokinetic study 93
Principles and current issues of antiepileptic drug therapy 93
LAMOTRIGINE IN RESISTANT CHILDHOOD EPILEPSY 92
Neuroprotective effects of lamotrigine and remacemide on excitotoxicity induced by glutamate agonists in isolated chick retina 92
Limited place for plasma monitoring of new antiepileptic drugs in clinicalpractice. 90
Il significato del monitoraggio dei farmaci nella compliance 90
THE INFLUENCE OF ELECTROENCEPHALOGRAPHIC FOCUS LATERALITY ON EFFICACY OF CARBAMAZEPINE IN COMPLEX PARTIAL AND SECONDARILY GENERALIZED TONIC-CLONIC SEIZURES 88
Totale 12.958
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.949
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021254 0 0 0 0 0 0 0 0 0 101 91 62
2021/20221.118 19 167 23 42 22 3 66 55 25 152 194 350
2022/20232.741 235 172 96 214 257 257 29 182 1.156 17 80 46
2023/2024637 68 122 60 69 46 130 15 26 2 29 8 62
2024/20253.325 55 45 89 154 158 75 41 962 867 151 188 540
2025/20268.299 268 615 572 764 692 2.129 989 1.029 992 249 0 0
Totale 19.466